about
Nanotechnology in neurology: Genesis, current status, and future prospectsLeukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory diseaseReview of the pharmacoeconomics of early treatment of multiple sclerosis using interferon betaMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesCorrelation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissueNatalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosisAstrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelinationCentral auditory processing and word discrimination in patients with multiple sclerosis.A composite likelihood approach to the analysis of longitudinal clonal data on multitype cellular systems under an age-dependent branching process.Prevalence of celiac disease in multiple sclerosis.Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina.Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination.Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.Tissue-engineered microenvironment systems for modeling human vasculatureAsymptotic behavior of cell populations described by two-type reducible age-dependent branching processes with non-homogeneous immigration().Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAILNeurodegenerative disorders and nanoformulated drug development.Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harmOsteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.Effects of transcranial magnetic stimulation on oxidative stress in experimental autoimmune encephalomyelitis.Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?Paradigms in multiple sclerosis: time for a change, time for a unifying concept.Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model.Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood.Association of AIRE Polymorphism and the Susceptibility to Multiple Sclerosis in Iranian Population.Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease ManagementThe release of cytokines by macrophages is not affected by myelin ingestionImpact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple SclerosisMyelin matters: proteomic insights into white matter disordersTherapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients
P2860
Q26771772-AB9F7E29-50E7-4BD2-B51F-6725042D5594Q26822941-9D7C3C6B-E827-43C0-816C-4DCBB063444FQ26864418-ECCC4A27-C063-4CF8-BC03-36A43C2068E6Q27011014-B12F689B-691B-4652-B558-181646D92E7EQ28477087-6F25D8BF-8F53-42D3-AA7D-CC1897C9E064Q28484467-A6C63D54-668A-4392-9004-968D349912DEQ29248440-CA534D21-EB9D-49C9-936F-A975E6A69A88Q30428908-303DE9B2-4506-414E-9E2A-9F5E4CE64A12Q33669914-40528DF4-E365-42DD-809D-1059EB803A20Q33840141-C0A06E64-CC4D-4F6E-88D3-DA559DBAB220Q34603641-7368EBB7-E9A7-4497-AD68-7A7E0F0CD2D7Q35154391-A3767074-E3C7-47ED-A9B2-B997BC12174CQ35193921-6809A6BC-9B1E-4381-BD49-246C9C5A7C78Q35536405-63F9B152-E06B-4D63-80BC-3FF9F46CC9F0Q35606563-412E0925-FEF8-4019-8419-305C41C2EBEEQ35748045-C853591B-855F-49CF-A89C-63EF0CE8E0C8Q36308323-C3CCFF2C-5563-477A-94DC-89B13020A9F6Q36353053-FBD9DD9E-304D-459C-B404-DD5BF5D4F2A2Q36690605-7605CE0B-6724-42DF-9465-F63CF3A184E2Q37538771-DDF0BE5B-8653-4820-BB97-AAB656C9B698Q37576442-849F7314-678D-47E3-B4C4-8CD4C3ED0FFBQ38215692-41D2FBAB-8F9D-4A8A-BE82-87C6095C3162Q38809422-FB9E4D29-5BA7-4BF7-A536-2427557F39A2Q41486516-9F6770AA-8391-4F39-A2C1-68E081EF89E8Q41886918-1AED7099-AA31-4CDE-8783-F4D0349E19D8Q41905360-41AD241C-8644-4CDA-B449-A448788C5D58Q43752834-6843E14B-06C4-49F3-BC79-43C85111611AQ46816215-6053F52E-A1CE-4D68-867C-8877A7D40AE8Q51049988-24648007-6BB2-4E5D-ABCE-4FDAF59DF1C3Q51052730-609A789E-CFCC-46DB-B260-F1E05B3DC288Q54209318-17E0B0A7-498A-4204-B206-3E08F3DF97AFQ54410992-8BDDC919-237A-487A-9675-4837E6FE4C3BQ55222177-0A1F9EF2-425F-4FC0-9253-D8222F36DDC8Q57169956-AFBC5F38-15F0-4296-8EB7-A3F94CF74670Q57261975-7647B78A-3E8B-4A07-9EB2-91AB9BFDC8BDQ57470698-5C5498B9-370D-432E-B123-5FDAD702A059Q57957934-9CA8CCF3-F75E-442C-9B94-5BE2BDF3B353Q58121520-2BC12C2B-06B2-4F41-95B6-19DC87457F1F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of multiple sclerosis.
@en
Pathophysiology of multiple sclerosis.
@nl
type
label
Pathophysiology of multiple sclerosis.
@en
Pathophysiology of multiple sclerosis.
@nl
prefLabel
Pathophysiology of multiple sclerosis.
@en
Pathophysiology of multiple sclerosis.
@nl
P1433
P1476
Pathophysiology of multiple sclerosis.
@en
P2860
P2888
P356
10.1007/S00415-008-6001-2
P478
255 Suppl 6
P50
P577
2008-12-01T00:00:00Z